⌂
Home
◈
Markets
▦
Screener
📈
Tools
◎
Portfolio
Skip to content
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,703.04
+0.57%
Nasdaq 100
29,560.53
+1.28%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.37
+1.51%
NYSE:TSM
$420.83
+1.99%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,146.83
−0.45%
Brent
$109.76
−0.05%
BTC
$81,861.47
−0.19%
ETH
$2,393.88
−0.56%
DFM General
5,851.39
−0.27%
FTSE ADX
9,783.24
−0.26%
TASI
10,123.62
−0.65%
QE Index
8,632.66
−0.01%
S&P 500
7,703.04
+0.57%
Nasdaq 100
29,560.53
+1.28%
Nifty 50
22,888.95
−1.11%
Sensex
73,852.90
−1.17%
KSE-100
165,966.09
−0.27%
DFM:EMIRATESNBD
AED 31.50
−0.25%
ADX:IHC
AED 352.00
−0.17%
SAU:2222
SAR 25.80
+0.00%
DSMD:QNBK
QAR 15.66
+2.29%
NAS:NVDA
$217.37
+1.51%
NYSE:TSM
$420.83
+1.99%
NSE:RELIANCE
₹1,202.00
−0.76%
KAR:OGDC
Rs 299.47
+0.12%
Gold
$4,146.83
−0.45%
Brent
$109.76
−0.05%
BTC
$81,861.47
−0.19%
ETH
$2,393.88
−0.56%
☰
Markets
▼
Stock markets
🇦🇪
UAE
DFM · ADX · DFM General
Closed
🇸🇦
Saudi Arabia
Tadawul · TASI
Closed
🇶🇦
Qatar
QSE · QE General
Closed
🇺🇸
United States
Nasdaq · NYSE · S&P 500
Open
🇮🇳
India
NSE · BSE · Nifty 50
Closed
🇵🇰
Pakistan
PSX · KSE-100
Closed
Other assets
₿
Crypto
Ranked by volume · 24/7
🥇
Gold, FX & economy
Dubai gold, AED crosses, rates
◫
ETFs
Index, sector and gold funds
Explore
▦
Market map
Every market as a heatmap
📅
Calendar & IPOs
Earnings, dividends, listings, releases
⌁
Options flow · Ownership · Politics
US filings and tapes
Screener
▼
⚲
Stock screener
All six markets, one row per company
★
Ready-made screens
Starting points with a point of view
📁
My saved screens
Saved rules with alerts on new matches
⇄
Compare
Up to five, side by side
Crypto
Tools
▼
📈
Charting
Drawings, indicators, replay
▶
Strategy Maker
Write a rule, test it on history
⇄
Compare
Side by side
🔔
Alerts
Price, earnings, screens, strategies
News
Portfolio
⌕
AED
USD
SAR
QAR
INR
PKR
GBP
EUR
KWD
OMR
BHD
☆
♢
☾
Sign in
Create account
👤
Markets
›
United States
› NAS
› ILMN
I
Illumina Inc
NAS:ILMN
Healthcare
NASDAQ:NBI
NASDAQ:NQUSMG
$264.37
+0.70%
Live
In session · ≈
AED 970.90
· Market cap
$39.92B
· Next earnings
Thu 29 Oct
☆
Watch
🔔
Alert
⇄
Compare
▶
Test a strategy
✦
AI read
Overview
Chart
Financials
Valuation
Forecasts
Dividends
Ownership
Options
Shorts
News
Profile
Illumina Inc · News · TradingHolo
ILMN news
Headlines tagged to this company
TR
Illumina, Inc. (ILMN) Launches BioInsight Platform With DRAGEN v4.6
TradingView · 5 d ago
RE
Pharma sector doubles down on AI to slash costs, timelines
Reuters · 5 d ago
TR
Illumina Launches $1.0 Billion Unsecured Commercial Paper Program; Signs Dealer Agreements
TradingView · 6 d ago
RE
Illumina - Establishes Unsecured Commercial Paper Program On October 8, 2026
Reuters · 6 d ago
DO
Grail Price Target Raised to $120.00/Share From $60.00 by Morgan Stanley
Dow Jones Newswires · 6 d ago
DO
Illumina Is Maintained at Hold by TD Cowen
Dow Jones Newswires · 6 d ago
TR
Illumina, Inc. Stock 12‑Month Price Target Raised to $237.16, Implies 10% Downside
TradingView · 10 d ago
RE
Illumina To Announce Third Quarter 2026 Financial Results
Reuters · 11 d ago
RE
Illumina Releases Spliceai2 To Help Advance Rare Disease Research
Reuters · 11 d ago
PR
Illumina releases SpliceAI2 to help advance rare disease research
PR Newswire · 11 d ago
DO
Illumina Price Target Raised to $200.00/Share From $160.00 by Barclays
Dow Jones Newswires · 12 d ago
SE
Top 10 Q3 insider stock sellers led by Nvidia’s Stevens, Jeff Bezos
Seeking Alpha · 12 d ago
DP
Biotech Stocks At 52-Week Highs - PCVX +31% On Phase 3 Results, INFU, ILMN +7%, CRL+7%, HTFL +5%
dpa-AFX · 13 d ago
ST
Illumina (ILMN) Shares Skyrocket, What You Need To Know
Stock Story · 14 d ago
DO
Illumina Is Maintained at Outperform by RBC Capital
Dow Jones Newswires · 14 d ago
TR
RBC Capital maintains Outperform rating on Illumina, $310 price target
TradingView · 14 d ago
SE
Moderna, Illumina lead healthcare gains in September as medtech drags
Seeking Alpha · 16 d ago
RE
Grail's cancer blood test nears landmark FDA approval, but insurance coverage looms
Reuters · 17 d ago
DO
Grail Price Target Raised to $155.00/Share From $75.00 by Guggenheim
Dow Jones Newswires · 18 d ago
More news →